Fig. 6From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties3D and 2D docking interaction of compound 8d with DHFR in compered to the slandered PRD400Back to article page